BGI Genomics Co Ltd (300676) — Capital Reinvestment Ratio
BGI Genomics Co Ltd (300676) has a Capital Reinvestment Ratio of 0.69x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥238.54 Million) in capital expenditures (CN¥165.34 Million). See net asset quality index of BGI Genomics Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BGI Genomics Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks BGI Genomics Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check 300676 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for BGI Genomics Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for BGI Genomics Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see BGI Genomics Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 5.53x | CN¥95.72 Million | CN¥529.48 Million | ▲ +82.9% |
| 2023 | 3.02x | CN¥408.77 Million | CN¥1.24 Billion | ▼ -68.7% |
| 2022 | 9.68x | CN¥130.88 Million | CN¥1.27 Billion | ▲ +6148.1% |
| 2021 | 0.15x | CN¥2.48 Billion | CN¥383.52 Million | ▲ +85.3% |
| 2020 | 0.08x | CN¥3.60 Billion | CN¥301.15 Million | ▼ -97.0% |
| 2019 | 2.79x | CN¥224.25 Million | CN¥626.44 Million | ▼ -93.9% |
| 2018 | 46.17x | CN¥14.69 Million | CN¥678.13 Million | ▲ +3761.6% |
| 2017 | 1.20x | CN¥243.66 Million | CN¥291.33 Million | ▲ +13.8% |
| 2016 | 1.05x | CN¥234.07 Million | CN¥246.01 Million | ▲ +94.9% |
| 2015 | 0.54x | CN¥328.68 Million | CN¥177.26 Million | ▼ -93.1% |
| 2013 | 7.76x | CN¥36.70 Million | CN¥284.88 Million | ▲ +809.1% |
| 2012 | 0.85x | CN¥72.49 Million | CN¥61.89 Million | — |